Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Errata: Vol. 62, No. RR-7
In the Recommendations and Reports, "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014," three errors occurred.
On page 22, the last sentence of the third paragraph under the subheading "Fluarix Quadrivalent" should read, "Overall frequencies of most solicited adverse events associated with Fluarix Quadrivalent in these studies were generally similar to these reported for the comparator trivalent vaccines."
On page 23, the second sentence of the first paragraph under the subheading "Flulaval Quadrivalent" should read, "Flulaval Quadrivalent will be available alongside the trivalent formulation of Flulaval during the 2013–14 season."
On page 23, the third sentence of the second paragraph under the subheading "Flulaval Quadrivalent" should read, "Contraindications and precautions to the administration of Flulaval Quadrivalent are similar to those described for the trivalent formulation of Flulaval (see Contraindications and Precautions for the Use of IIV; Table 2) (345)."
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.